These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 25701675)
1. Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Lee SJ; Song L; Yang MC; Mao CP; Yang B; Yang A; Jeang J; Peng S; Wu TC; Hung CF Vaccine; 2015 Mar; 33(13):1549-55. PubMed ID: 25701675 [TBL] [Abstract][Full Text] [Related]
2. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract. Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Lee SY; Kang TH; Knoff J; Huang Z; Soong RS; Alvarez RD; Hung CF; Wu TC Cancer Immunol Immunother; 2013 Jul; 62(7):1175-85. PubMed ID: 23615841 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297 [TBL] [Abstract][Full Text] [Related]
5. Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA. Kang TH; Chung JY; Monie A; Pai SI; Hung CF; Wu TC Gene Ther; 2010 Apr; 17(4):531-40. PubMed ID: 19940864 [TBL] [Abstract][Full Text] [Related]
6. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy. Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446 [TBL] [Abstract][Full Text] [Related]
7. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors. Sun Y; Peng S; Qiu J; Miao J; Yang B; Jeang J; Hung CF; Wu TC Gene Ther; 2015 Jul; 22(7):528-35. PubMed ID: 25786869 [TBL] [Abstract][Full Text] [Related]
8. Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Zeng Q; Peng S; Monie A; Yang M; Pang X; Hung CF; Wu TC Hum Gene Ther; 2011 Jul; 22(7):809-19. PubMed ID: 21128743 [TBL] [Abstract][Full Text] [Related]
9. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice. Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858 [TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination. Lee SY; Huang Z; Kang TH; Soong RS; Knoff J; Axenfeld E; Wang C; Alvarez RD; Chen CS; Hung CF; Wu TC J Mol Med (Berl); 2013 Oct; 91(10):1221-31. PubMed ID: 23715898 [TBL] [Abstract][Full Text] [Related]
12. Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells. Choi YW; Kang MC; Seo YB; Namkoong H; Park Y; Choi DH; Suh YS; Lee SW; Sung YC; Jin HT Clin Cancer Res; 2016 Dec; 22(23):5898-5908. PubMed ID: 27407095 [TBL] [Abstract][Full Text] [Related]
13. Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity. Seo SH; Han HD; Noh KH; Kim TW; Son SW Clin Exp Metastasis; 2009; 26(3):179-87. PubMed ID: 19082918 [TBL] [Abstract][Full Text] [Related]
14. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF. Zhang SN; Choi IK; Huang JH; Yoo JY; Choi KJ; Yun CO Mol Ther; 2011 Aug; 19(8):1558-68. PubMed ID: 21468000 [TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine. Thomas MC; Greten TF; Pardoll DM; Jaffee EM Hum Gene Ther; 1998 Apr; 9(6):835-43. PubMed ID: 9581906 [TBL] [Abstract][Full Text] [Related]
16. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma. Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012 [TBL] [Abstract][Full Text] [Related]
17. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. Hurwitz AA; Yu TF; Leach DR; Allison JP Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10067-71. PubMed ID: 9707601 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine. Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962 [TBL] [Abstract][Full Text] [Related]